Unicycive Therapeutics Narrows Net Loss and Awaits FDA Facility Inspection for Lead Candidate OLC
Market Chameleon (Wed, 12-Aug 8:45 AM)
FDA Review for Unicycive’s Oxylanthanum Carbonate Focuses on Third-Party Manufacturing—Efficacy and Safety Remain Unchallenged
Market Chameleon (Tue, 30-Jun 7:31 AM)
